NO20020920D0 - Anvendelse av leptin til å inhibere endotelcelleproliferasjon - Google Patents

Anvendelse av leptin til å inhibere endotelcelleproliferasjon

Info

Publication number: NO20020920D0
Authority: NO; Norway
Prior art keywords: leptin; cell proliferation; endothelial cell; inhibit endothelial; inhibit
Prior art date: 1999-09-05

Application number

NO20020920A

Other languages

English (en)

Other versions

NO20020920L (no

NO325989B1 (no

Inventor

Menachem Rubinstein

Batya Cohen

Dalit Barkan

Original Assignee

Yeda Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-05

Filing date

2002-02-25

Publication date

2002-02-25

1999-09-05 Priority claimed from IL13173999A external-priority patent/IL131739A0/xx

2002-02-25 Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev

2002-02-25 Publication of NO20020920D0 publication Critical patent/NO20020920D0/no

2002-05-03 Publication of NO20020920L publication Critical patent/NO20020920L/no

2008-09-01 Publication of NO325989B1 publication Critical patent/NO325989B1/no

Links

102000016267 Leptin Human genes 0.000 title 1
108010092277 Leptin Proteins 0.000 title 1
230000004663 cell proliferation Effects 0.000 title 1
210000002889 endothelial cell Anatomy 0.000 title 1
NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 title 1
229940039781 leptin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/484—Plasmin (3.4.21.7)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Oncology (AREA)
Zoology (AREA)
Diabetes (AREA)
Genetics & Genomics (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20020920A 1999-09-05 2002-02-25 Anvendelse av leptin, i kombinasjon med en hemmer av VEGF og/eller angiogenese, for a hemme angiogenese. NO325989B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IL13173999A IL131739A0 (en)	1999-09-05	1999-09-05	Use of leptin in inhibition of endothelial cell proliferation
IL13231299A IL132312A0 (en)	1999-09-05	1999-10-10	Use of leptin in inhibition of endothelial cell proliferation
PCT/IL2000/000525 WO2001018040A2 (en)	1999-09-05	2000-09-04	Use of leptin in inhibition of endothelial cell proliferation

Publications (3)

Publication Number	Publication Date
NO20020920D0 true NO20020920D0 (no)	2002-02-25
NO20020920L NO20020920L (no)	2002-05-03
NO325989B1 NO325989B1 (no)	2008-09-01

Family

ID=26323878

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20020920A NO325989B1 (no)	1999-09-05	2002-02-25	Anvendelse av leptin, i kombinasjon med en hemmer av VEGF og/eller angiogenese, for a hemme angiogenese.

Country Status (19)

Country	Link
EP (1)	EP1210108B1 (no)
JP (1)	JP2003508544A (no)
KR (1)	KR100683362B1 (no)
CN (1)	CN1189479C (no)
AR (1)	AR025494A1 (no)
AT (1)	ATE449609T1 (no)
AU (1)	AU781390B2 (no)
BR (1)	BR0013778A (no)
CA (1)	CA2382941C (no)
DE (1)	DE60043391D1 (no)
EA (1)	EA005066B1 (no)
EE (1)	EE05262B1 (no)
ES (1)	ES2335569T3 (no)
HK (1)	HK1048075B (no)
IL (1)	IL132312A0 (no)
MX (1)	MXPA02002448A (no)
NO (1)	NO325989B1 (no)
UA (1)	UA74163C2 (no)
WO (1)	WO2001018040A2 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6355237B1 (en) *	1994-09-14	2002-03-12	Progenitor, Inc.	Methods for using the obese gene and its gene product to stimulate hematopoietic development
US8633250B2 (en) *	2006-01-12	2014-01-21	Musc Foundation For Research Development	Cell repair and regeneration by suramin and related polysulfonated napthylureas
ES2474765T3 (es) *	2009-06-17	2014-07-09	National University Corporation Kumamoto University	Agente profiláctico y/o terapéutico para la dismenorrea

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2260784T3 (es) *	1996-01-23	2006-11-01	Indevus Pharmaceuticals, Inc.	Metodos de utilizacion del gen obese y su producto genico para estimular el desarrolo hematopoyetico.
IT1288388B1 (it) *	1996-11-19	1998-09-22	Angeletti P Ist Richerche Bio	Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
IL120733A0 (en) *	1997-04-29	1997-08-14	Yeda Res & Dev	Leptin as an inhibitor of cell proliferation
AU4672199A (en) *	1998-05-20	1999-12-06	Yale University	Modulation of angiogenesis and wound healing

1999
- 1999-10-10 IL IL13231299A patent/IL132312A0/xx unknown
2000
- 2000-04-09 UA UA2002042717A patent/UA74163C2/uk unknown
- 2000-09-04 EA EA200200331A patent/EA005066B1/ru not_active IP Right Cessation
- 2000-09-04 CN CNB00813748XA patent/CN1189479C/zh not_active Expired - Fee Related
- 2000-09-04 MX MXPA02002448A patent/MXPA02002448A/es active IP Right Grant
- 2000-09-04 ES ES00956758T patent/ES2335569T3/es not_active Expired - Lifetime
- 2000-09-04 EP EP00956758A patent/EP1210108B1/en not_active Expired - Lifetime
- 2000-09-04 WO PCT/IL2000/000525 patent/WO2001018040A2/en not_active Ceased
- 2000-09-04 KR KR1020027002112A patent/KR100683362B1/ko not_active Expired - Fee Related
- 2000-09-04 AR ARP000104622A patent/AR025494A1/es unknown
- 2000-09-04 HK HK03100442.1A patent/HK1048075B/zh not_active IP Right Cessation
- 2000-09-04 DE DE60043391T patent/DE60043391D1/de not_active Expired - Lifetime
- 2000-09-04 JP JP2001522262A patent/JP2003508544A/ja active Pending
- 2000-09-04 BR BR0013778-2A patent/BR0013778A/pt not_active Application Discontinuation
- 2000-09-04 AT AT00956758T patent/ATE449609T1/de not_active IP Right Cessation
- 2000-09-04 AU AU68620/00A patent/AU781390B2/en not_active Ceased
- 2000-09-04 CA CA2382941A patent/CA2382941C/en not_active Expired - Fee Related
- 2000-09-04 EE EEP200200116A patent/EE05262B1/xx not_active IP Right Cessation
2002
- 2002-02-25 NO NO20020920A patent/NO325989B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
ES2335569T3 (es)	2010-03-30
AU6862000A (en)	2001-04-10
JP2003508544A (ja)	2003-03-04
BR0013778A (pt)	2002-05-14
NO20020920L (no)	2002-05-03
EE200200116A (et)	2003-04-15
EP1210108B1 (en)	2009-11-25
CN1189479C (zh)	2005-02-16
EP1210108A2 (en)	2002-06-05
WO2001018040A2 (en)	2001-03-15
HK1048075A1 (en)	2003-03-21
NO325989B1 (no)	2008-09-01
MXPA02002448A (es)	2002-07-30
EA005066B1 (ru)	2004-10-28
CA2382941C (en)	2011-08-16
ATE449609T1 (de)	2009-12-15
DE60043391D1 (de)	2010-01-07
CN1377277A (zh)	2002-10-30
EE05262B1 (et)	2010-02-15
HK1048075B (zh)	2005-07-29
UA74163C2 (uk)	2005-11-15
WO2001018040A3 (en)	2001-06-14
KR100683362B1 (ko)	2007-02-15
AR025494A1 (es)	2002-11-27
IL132312A0 (en)	2001-03-19
KR20020040781A (ko)	2002-05-30
EA200200331A1 (ru)	2002-08-29
CA2382941A1 (en)	2001-03-15
AU781390B2 (en)	2005-05-19

Publication	Publication Date	Title
ATE269327T1 (de)	2004-07-15	Imidazol-5-yl-2-anilino-pyrimidine als inhibitoren der zellproliferation
DE60020100D1 (de)	2005-06-16	Dimerverbindungen und als inhibitoren der neuramidinase
NO20022979L (no)	2002-06-20	Anvendelse av organiske forbindelser
DK1181269T3 (da)	2004-07-05	Celleproliferationsinhibitorer
NO20013770L (no)	2001-09-27	Metoder og blandinger for å öke antall hvite blodceller
IS6120A (is)	2001-10-22	Lyfjablanda
DE60009675D1 (de)	2004-05-13	Protonenpumpinhibitoren enthaltende zusammensetzung
ITMI991754A0 (it)	1999-08-04	Composizioni cosmetiche
NO20015112L (no)	2001-12-10	Anvendelse av glykosylceramidsynteseinhibitorer ved terapi
FI20000155L (fi)	2000-07-28	Karstaa ja/tai korroosiota estävä koostumus
DE69827942D1 (de)	2005-01-05	Leptin als inhibitor der tumorzellenproliferation
NO20013507D0 (no)	2001-07-13	Sammensetning til å behandle inflammatorisk respons
DE60329687D1 (de)	2009-11-26	Topische wasser-und ethanolfreie Pimecrolimus enthaltende Zusammensetzungen
ATE269349T1 (de)	2004-07-15	Derivativen von monosacchariden als zelladhäsionshemmer
NO20004579D0 (no)	2000-09-14	Substituerte bisindolymaleimider for inhibering av celle- proliferering
ATE277023T1 (de)	2004-10-15	Indanderivate und ihre verwendung als zelladhäsionsinihibitoren
ATE250074T1 (de)	2003-10-15	2,3-o-isoproylidene derivativen von monosacchariden und verwendung als zell-adhäsion- inhibitoren
NO20020920D0 (no)	2002-02-25	Anvendelse av leptin til å inhibere endotelcelleproliferasjon
LU90483B1 (fr)	2001-01-31	Compositions nouvelles de m-thanesulfonate de parox-tine
FR2791258B1 (fr)	2001-08-24	Composition amincissante
DE60020682D1 (de)	2005-07-14	Resorcinenthaltende zusammensetzung
NO20022776L (no)	2002-06-11	Substituerte bisindolylmaleimider for inhibering av celleproliferasjon
NO20014697D0 (no)	2001-09-27	Anvendelse av vasopeptidaseinhibitorer for å behandle angina pectoris
ID30381A (id)	2001-11-29	Penggunaan arilalkanoilpiridazina
ATE260259T1 (de)	2004-03-15	Substituierte isochinolinderivate und ihre verwendung als anticonvulsiva

Legal Events

Date	Code	Title	Description
2014-04-28	MM1K	Lapsed by not paying the annual fees